Chengdu Kanghua Biological Products (300841) — Cash Flow-to-Debt Ratio
Chengdu Kanghua Biological Products (300841) has a Cash Flow-to-Debt Ratio of 0.22x as of September 2025, meaning its operating cash flow of CN¥92.89 Million could theoretically repay 0% of its total liabilities (CN¥430.82 Million) in one year. See Chengdu Kanghua Biological Products leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chengdu Kanghua Biological Products Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Chengdu Kanghua Biological Products across 10 annual periods. For the full cash flow conversion analysis, see 300841 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year debt coverage analysis for Chengdu Kanghua Biological Products. Check Chengdu Kanghua Biological Products cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | CN¥572.24 Million | CN¥580.07 Million | ▲ +19.5% |
| 2023 | 0.83x | CN¥573.98 Million | CN¥695.22 Million | ▲ +169.0% |
| 2022 | 0.31x | CN¥194.99 Million | CN¥635.40 Million | ▼ -18.1% |
| 2021 | 0.37x | CN¥130.33 Million | CN¥347.74 Million | ▼ -82.4% |
| 2020 | 2.13x | CN¥369.56 Million | CN¥173.24 Million | ▲ +33.7% |
| 2019 | 1.60x | CN¥182.73 Million | CN¥114.49 Million | ▲ +229.4% |
| 2018 | 0.48x | CN¥57.35 Million | CN¥118.37 Million | ▼ -53.5% |
| 2017 | 1.04x | CN¥89.96 Million | CN¥86.38 Million | ▲ +11610.7% |
| 2016 | 0.01x | CN¥2.64 Million | CN¥297.23 Million | ▼ -62.7% |
| 2015 | 0.02x | CN¥6.51 Million | CN¥272.61 Million | — |